Is Urolithin A Safe?
Safety cannot be answered with a simple yes or no. It depends on the ingredient specification, amount, duration, product quality, user and route of exposure.
What studies have found
A published safety assessment included genetic-toxicity testing and repeated-dose animal studies.[11] The 2019 first-in-human trial reported a favourable safety profile at the tested single and repeated doses over four weeks.[2]
In the four-month JAMA trial, no statistical difference in adverse events was found between Urolithin A and placebo.[4] The middle-aged adult trial also reported supplementation as safe under its study conditions.[5]
These results are reassuring for the specific products, populations, amounts and durations studied.
What “well tolerated” does not mean
It does not mean:
- zero participants experienced symptoms;
- every commercial product has equivalent purity;
- there are no rare reactions;
- it is safe in pregnancy or children;
- it cannot interact with medicines;
- indefinite use is established as safe;
- larger amounts are safe.
Evidence gaps
Most influential human trials lasted four weeks to four months. Long-term surveillance and studies in medically complex populations are limited.[2,4-7]
Published trials often excluded pregnant people, people with substantial chronic disease, clinically significant laboratory abnormalities or recent antibiotic use. Exclusion improves trial control but reduces certainty for real-world users.
Medicines and interactions
A reliable interaction profile has not been established. Consumers should not interpret “no known interactions” as “proven not to interact.” Metabolism, transporters, gut microbiome changes and combined physiological effects can create interactions that small trials are not designed to detect.
Ask a pharmacist or clinician to review the exact product and your medicines.
Pregnancy, breastfeeding and fertility
There is insufficient human evidence to recommend oral Urolithin A during pregnancy or breastfeeding. Avoid routine use unless an appropriately qualified clinician who understands the product and circumstances advises otherwise.
Children and teenagers
The principal human studies were conducted in adults. Do not extrapolate adult research doses to children. Products should be kept out of children’s reach.
Older and frail adults
Although several studies focused on older adults, trial participants were selected and monitored. A frail person with multiple medicines and illnesses may have a different risk profile from a healthy trial volunteer.
Allergy and product ingredients
Purified Urolithin A is not the only possible source of a reaction. Capsules, gummies and powders can contain flavourings, sweeteners, colourants, oils, emulsifiers and allergens. Read the full label.
Cosmetic safety
A topical product requires a cosmetic product safety assessment and compliance with the applicable cosmetic rules. Patch-testing claims and “dermatologist tested” wording do not guarantee that no consumer will react. Stop use if persistent irritation occurs.
When to seek help
Seek urgent medical help for difficulty breathing, facial or throat swelling, collapse or other features of a severe allergic reaction.
Contact an appropriate healthcare professional for persistent rash, gastrointestinal symptoms, unexpected weakness or other symptoms that appear after starting a product.
Safety conclusion
Short controlled studies are broadly reassuring for studied adult populations. The responsible statement is that Urolithin A was generally well tolerated under the conditions of available trials, not that it is universally or permanently safe.